Ancora Advisors’s LakeShore Biopharma Warrants LSBPW Stock Holding History

Ancora Advisors’s Portfolio LSBPW Stock Details LSBPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3	Hold	5,050	–	–	﹤0.01%	1980
2026 Q1	$18	Hold	5,050	–	–	﹤0.01%	2370
2025 Q4	$15	Hold	5,050	–	–	﹤0.01%	2412
2025 Q3	$7	Hold	5,050	–	–	﹤0.01%	1954
2025 Q2	$201	Hold	5,050	–	–	﹤0.01%	1898
2025 Q1	$208	Hold	5,050	–	–	﹤0.01%	1699
2024 Q4	$401	Hold	5,050	–	–	﹤0.01%	1688
2024 Q3	$334	Hold	5,050	–	–	﹤0.01%	1658
2024 Q2	$444	Hold	5,050	–	–	﹤0.01%	1714
2024 Q1	$362	Hold	5,050	–	–	﹤0.01%	1701
2023 Q4	$192	Hold	5,050	–	–	﹤0.01%	1655
2023 Q3	$208	Hold	5,050	–	–	﹤0.01%	1692
2023 Q2	$237	Hold	5,050	–	–	﹤0.01%	1694
2023 Q1	$786	Buy	+5,050	New	+$765	﹤0.01%	1656

Ancora Advisors's LSBPW Position: Q2 2026 in Review

Ancora Advisors held its LakeShore Biopharma Warrants (LSBPW) position steady in Q2 2026 at 5,050 shares worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #1980.

Ancora Advisors first reported a position in LSBPW in Q1 2023 and has held it in 14 quarters since. The position peaked at $786 in Q1 2023. 1 fund tracked by Wall St. Rank holds LSBPW as of Q2 2026.

Ancora Advisors held 5,050 shares of LakeShore Biopharma Warrants worth $3 as of Q2 2026.
Ancora Advisors left its LakeShore Biopharma Warrants share count unchanged in Q2 2026.
LakeShore Biopharma Warrants made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #1980 holding.
Ancora Advisors first reported a position in LakeShore Biopharma Warrants in Q1 2023 and has held it in 14 quarters since.
Ancora Advisors's LakeShore Biopharma Warrants position peaked at $786 in Q1 2023.
1 fund tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.